Aeluma Insider Sold Shares Worth $345,741, According to a Recent SEC Filing
MT newswire2026/08/28 20:47Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moderna melanoma vaccine data gains recognition; fifth institution upgrades rating
Moderna has recently received consecutive rating upgrades from five institutions due to positive clinical data from its melanoma mRNA cancer vaccine. Argus analyst Hellweg upgraded the company's rating from "hold" to "buy," noting that the stock price is currently trading at over a 70% discount from its historical peak and believing that "the tide is turning." He emphasized that the stock price increase driven by existing data is just the beginning, and that continued positive confirmatory data will provide stronger upward momentum.
South Korean Won: Higher rates and chip boom support gains – ING
AJB Investment Fund II reports buying Jewett-Cameron common shares worth $7,350.20
Morgan Stanley trims ADTRAN stake to 6.77% from 6.8%
Crypto prices
More
